This is an excellent and clear description of genetics vs genomics in the cancer world. “In this episode of the No One Missed: Biomarker Testing in MBC series, watch Jenny Burkholder, patient advocate and podcast host, discuss the concept of precision medicine with Dr. Mehta, MD, of MD Anderson Cancer Center, the essential differences between genetic and genomic testing in metastatic cancer care, how advancements like next-generation sequencing have transformed genomic testing, making it more accessible and less invasive, and why these tests are vital for selecting targeted therapies in metastatic breast cancer.” (From Living Beyond Breast Cancer)
Click here to watch the video
